Login / Signup

Observation and consideration on using of JAKi in clinical trials in times of COVID-19.

Jing YangMaher Al-MurieshLi YanXiangjie AnJuan Tao
Published in: Dermatologic therapy (2020)
Keyphrases
  • clinical trial
  • coronavirus disease
  • sars cov
  • phase ii
  • respiratory syndrome coronavirus
  • open label
  • phase iii
  • randomized controlled trial
  • study protocol